It’s well known that the more antibodies you are able to screen the greater your chances of finding a top performing pairing for your rapid antibody test.
Traditional screening techniques such as ELISA allow high throughput, however they can be time consuming to set-up and the data generated does not always translate well to lateral flow development.
Some contract developers will perform the rapid antibody screening directly using lateral flow assay. However, this will use high quantities of each antibody (1-5 mg) and throughput is less than using ELISA for screening. Therefore, the cost of purchasing the antibodies is high and time to complete the testing is long (1-3 months).
To solve these issues Lateral Dx has developed an innovative antibody screening method that is able to quickly, quantitatively and cost-effectively screen multiple antibodies for their suitability for use in the lateral flow test format. The system can work with antibody quantities of as little as 0.1 mg and results can be generated in 1-2 weeks.
Stay informed on the latest lateral flow test development and manufacture industry news, rapid antibody screening developments, our sample antibody conjugation projects and everything in between. Fill in the form below to start receiving our newsletter.